Sfrp5 expression and secretion in adipocytes are up-regulated during differentiation and are negatively correlated with insulin resistance

Cell Biology International

Volumn 36, Issue 9, 2012, Pages 851-855

  Lv, Ci ^a   Jiang, Youzhao ^a   Wang, Hui ^a   Chen, Bing ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

3T3 L1 pre adipocytes; Adipogenesis; Insulin resistance; Obese; Sfrp5

Indexed keywords

DEXAMETHASONE; INSULIN; MESSENGER RNA; METFORMIN; ROSIGLITAZONE; SECRETED FRIZZLED RELATED PROTEIN 5; TUMOR NECROSIS FACTOR;

ADIPOCYTE; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL STRAIN 3T3; CELL STRUCTURE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENETIC TRANSCRIPTION; INSULIN RESISTANCE; INSULIN SENSITIVITY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 84865082904     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1042/CBI20120054     Document Type: Article

References (31)

1. Ailhaud G, Grimaldi P, Negrel R. Cellular and molecular aspects of adipose tissue development. Annu Rev Nutr 1992;12:207-33.
2. Anedda A, Rial E, Gonzalez-Barroso MM. Metformin induces oxidative stress in white adipocytes and raises uncoupling protein 2 levels. J Endocrinol 2008;199:33-40.
3. Boden G, Cheung P, Mozzoli M, Fried SK. Effect of thiazolidinediones on glucose and fatty acid metabolism in patients with type 2 diabetes. Metabolism 2003;52:753-9.
4. Cho HJ, Park J, Lee HW, Lee YS, Kim JB. Regulation of adipocyte differentiation and insulin action with rapamycin. Biochem Biophys Res Commun 2004;321:942-8.
5. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol 2004;24:e13-8.
6. Gustafson B, Smith U. Cytokines promote Wnt signaling and inflammation and impair the normal differentiation and lipid accumulation in 3T3-L1 preadipocytes. J Biol Chem 2006;281:9507-16.
7. Hammarstedt A, Isakson P, Gustafson B, Smith U. Wnt-signaling is maintained and adipogenesis inhibited by TNFa but not MCP-1 and resistin. Biochem Biophysl Res Commun 2007;357:700-6.
8. He B, Lee AY, Dadfarmay S, You L, Xu Z, Reguart N et al. Secreted frizzled-related protein 4 is silenced by hypermethylation and induces apoptosis in b-catenin-deficient human mesothelioma cells. Cancer Res 2005;65:743-8.
9. He L, Sabet A, Djedjos S, Miller R, Sun X, Hussain MA et al. Metformin and insulin suppress hepatic gluconeogenesis through phosphorylation of CREB binding protein. Cell 2009;137:635-46.
10. Heilbronn LK, Campbell LV. Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity. Curr Pharm Des 2008;14:1225-30.
11. Hirosumi J, Tuncman G, Chang L, Görgün CZ, Uysal KT, Maeda K et al. A central role for JNK in obesity and insulin resistance. Nature 2002;420:333-6.
12. Hotamisligil GS. Inflammation and metabolic disease. Nature 2006;444:860-7.
13. Kajimoto K, Terada H, Baba Y, Shinohara Y. Essential role of citrate export from mitochondria at early differentiation stage of 3T3-L1 cells for their effective differentiation into fat cells, as revealed by studies using specific inhibitors of mitochondrial di-and tricarboxylate carriers. Mol Genet Metab 2005;85:46-53.
14. Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. AM J Physiol Endocrinol Metab 2001;280:E745-51.
15. Lee J, Lee J, Jung E, Hwang W, Kim YS, Park D. Isorhamnetin-induced anti-adipogenesis is mediated by stabilization of b-catenin protein. Life Sci 2010;86:416-23.
16. Lee H, Bae S, Kim K, Kim W, Chung SI, Yang Y, Yoon Y. Shikonin inhibits adipogenesis by modulation of the WNT/b-catenin pathway. Life Sci 2011;88:294-301.
17. Maury E, Noel L, Detry R, Brichard SM. In vitro hyper-responsiveness to TNFa contributes to adipokine dysregulation in omental adipocytes of obese subjects. J Clin Endocrinol Metab 2009;94:1393-400.
18. Ouchi N, Higuchi A, Ohashi K, Oshima Y, Gokce N, Shibata R et al. Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity. Science 2010;329:454-7.
19. Pajvani UB, Trujillo ME, Combs TP, Iyengar P, Jelicks L, Roth KA et al. Fat apoptosis through targeted activation of caspase 8: a new mouse model of inducible and reversible lipoatrophy. Nat Med 2005;11:797-803.
20. Pereira C, Schaer DJ, Bachli EB, Kurrer MO, Schoedon G. Wnt5A/CaMKII signaling contributes to the inflammatory response of macrophages and is a target for the antiinflammatory action of activated protein C and interleukin-10. Arterioscler Thromb Vasc Biol 2008;28:504-10.
21. Prusty D, Park BH, Davis KE, Farmer SR. Activation of MEK/ERK signaling promotes adipogenesis by enhancing peroxisome proliferator-activated receptor c (PPARc) and C/EBP alpha gene expression during the differentiation of 3T3-L1 preadipocytes. Biol Chem 2002;277:226-32.
22. Scherer PE. Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 2006;55:1537-45.
23. Schinner S, Willenberg HS, Schott M, Scherbaum WA. Pathophysiological aspects of Wnt-signaling in endocrine disease. Eur J Endocrinol 2009;160:731-7.
24. Solinas G, Vilcu C, Neels JG, Bandyopadhyay GK, Luo JL, Naugler W et al. JNK1 in hematopoietically derived cells contributes to dietinduced inflammation and insulin resistance without affecting obesity. Cell Metab 2007;6:386-97.
25. Suzuki H, Watkins DN, Jair KW, Schuebel KE, Markowitz SD, Chen WD et al. Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet 2004;36:417-22.
26. Takatani T, Minagawa M, Takatani R, Kinoshita K, Kohno Y. AMPactivated protein kinase attenuates Wnt/b-catenin signaling in human ostesblastic Saos-2 cells. Mol Cell Endocrinol 2011;339:114-9.
27. Vallerie SN, Furuhashi M, Fucho R, Hotamisligil GS. A predominant role for parenchymal c-Jun amino terminal kinase (JNK) in the regulation of systemic insulin sensitivity. PLoS One 2008;3:e3151.
28. Wang Y. Wnt/Planar cell polarity signaling: a new paradigm for cancer therapy. Mol Cancer Ther. 2009;8:2103-9.
29. Wagstaff AJ, Goa KL. Rosiglitazone: a review of its use in the management of type 2 diabetes mellitus. Drugs 2002;62:1805-37.
30. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest 2005;115:1111-9.
31. Yoshida T, Okuno A, Tanaka J, Takahashi K, Nakashima R, Kanda S et al. Metformin primarily decreases plasma glucose not by gluconeogenesis suppression but by activating glucose utilization in a non-obese type 2 diabetes Goto-Kakizaki rats. Eur J Pharmacol. 2009;62 3:141-7.